These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 21699179)

  • 1. Discovery of naturally occurring aurones that are potent allosteric inhibitors of hepatitis C virus RNA-dependent RNA polymerase.
    Haudecoeur R; Ahmed-Belkacem A; Yi W; Fortuné A; Brillet R; Belle C; Nicolle E; Pallier C; Pawlotsky JM; Boumendjel A
    J Med Chem; 2011 Aug; 54(15):5395-402. PubMed ID: 21699179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B-ring modified aurones as promising allosteric inhibitors of hepatitis C virus RNA-dependent RNA polymerase.
    Meguellati A; Ahmed-Belkacem A; Yi W; Haudecoeur R; Crouillère M; Brillet R; Pawlotsky JM; Boumendjel A; Peuchmaur M
    Eur J Med Chem; 2014 Jun; 80():579-92. PubMed ID: 24835816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New pseudodimeric aurones as palm pocket inhibitors of Hepatitis C virus RNA-dependent RNA polymerase.
    Meguellati A; Ahmed-Belkacem A; Nurisso A; Yi W; Brillet R; Berqouch N; Chavoutier L; Fortuné A; Pawlotsky JM; Boumendjel A; Peuchmaur M
    Eur J Med Chem; 2016 Jun; 115():217-29. PubMed ID: 27017550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-nucleoside Inhibitors of Zika Virus RNA-Dependent RNA Polymerase.
    Gharbi-Ayachi A; Santhanakrishnan S; Wong YH; Chan KWK; Tan ST; Bates RW; Vasudevan SG; El Sahili A; Lescar J
    J Virol; 2020 Oct; 94(21):. PubMed ID: 32796069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-genotypic examination of hepatitis C virus polymerase inhibitors reveals a novel mechanism of action for thumb binders.
    Eltahla AA; Tay E; Douglas MW; White PA
    Antimicrob Agents Chemother; 2014 Dec; 58(12):7215-24. PubMed ID: 25246395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of RNA binding to hepatitis C virus RNA-dependent RNA polymerase: a new mechanism for antiviral intervention.
    Ahmed-Belkacem A; Guichou JF; Brillet R; Ahnou N; Hernandez E; Pallier C; Pawlotsky JM
    Nucleic Acids Res; 2014 Aug; 42(14):9399-409. PubMed ID: 25053847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Broad-spectrum non-nucleoside inhibitors for caliciviruses.
    Netzler NE; Enosi Tuipulotu D; Eltahla AA; Lun JH; Ferla S; Brancale A; Urakova N; Frese M; Strive T; Mackenzie JM; White PA
    Antiviral Res; 2017 Oct; 146():65-75. PubMed ID: 28757394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of hepatitis C virus NS5B polymerase by S-trityl-L-cysteine derivatives.
    Nichols DB; Fournet G; Gurukumar KR; Basu A; Lee JC; Sakamoto N; Kozielski F; Musmuca I; Joseph B; Ragno R; Kaushik-Basu N
    Eur J Med Chem; 2012 Mar; 49():191-9. PubMed ID: 22280819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of hepatitis C viral RNA-dependent RNA polymerase by α-P-boranophosphate nucleotides: exploring a potential strategy for mechanism-based HCV drug design.
    Cheek MA; Sharaf ML; Dobrikov MI; Shaw BR
    Antiviral Res; 2013 May; 98(2):144-52. PubMed ID: 23466667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2'-deoxy-4'-azido nucleoside analogs are highly potent inhibitors of hepatitis C virus replication despite the lack of 2'-alpha-hydroxyl groups.
    Klumpp K; Kalayanov G; Ma H; Le Pogam S; Leveque V; Jiang WR; Inocencio N; De Witte A; Rajyaguru S; Tai E; Chanda S; Irwin MR; Sund C; Winqist A; Maltseva T; Eriksson S; Usova E; Smith M; Alker A; Najera I; Cammack N; Martin JA; Johansson NG; Smith DB
    J Biol Chem; 2008 Jan; 283(4):2167-75. PubMed ID: 18003608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-hepatitis C virus RdRp activity and replication of novel anilinobenzothiazole derivatives.
    Peng HK; Chen WC; Lin YT; Tseng CK; Yang SY; Tzeng CC; Lee JC; Yang SC
    Antiviral Res; 2013 Oct; 100(1):269-75. PubMed ID: 23994188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two RNA Tunnel Inhibitors Bind in Highly Conserved Sites in Dengue Virus NS5 Polymerase: Structural and Functional Studies.
    Arora R; Liew CW; Soh TS; Otoo DA; Seh CC; Yue K; Nilar S; Wang G; Yokokawa F; Noble CG; Chen YL; Shi PY; Lescar J; Smith TM; Benson TE; Lim SP
    J Virol; 2020 Nov; 94(24):. PubMed ID: 32907977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical study of the comparative inhibition of hepatitis C virus RNA polymerase by VX-222 and filibuvir.
    Yi G; Deval J; Fan B; Cai H; Soulard C; Ranjith-Kumar CT; Smith DB; Blatt L; Beigelman L; Kao CC
    Antimicrob Agents Chemother; 2012 Feb; 56(2):830-7. PubMed ID: 22143520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preclinical characterization of JTK-853, a novel nonnucleoside inhibitor of the hepatitis C virus RNA-dependent RNA polymerase.
    Ando I; Adachi T; Ogura N; Toyonaga Y; Sugimoto K; Abe H; Kamada M; Noguchi T
    Antimicrob Agents Chemother; 2012 Aug; 56(8):4250-6. PubMed ID: 22615294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of hepatitis C virus replication by Monascus pigment derivatives that interfere with viral RNA polymerase activity and the mevalonate biosynthesis pathway.
    Sun JM; Kim SJ; Kim GW; Rhee JK; Kim ND; Jung H; Jeun J; Lee SH; Han SH; Shin CS; Oh JW
    J Antimicrob Chemother; 2012 Jan; 67(1):49-58. PubMed ID: 22076990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro resistance study of AG-021541, a novel nonnucleoside inhibitor of the hepatitis C virus RNA-dependent RNA polymerase.
    Shi ST; Herlihy KJ; Graham JP; Fuhrman SA; Doan C; Parge H; Hickey M; Gao J; Yu X; Chau F; Gonzalez J; Li H; Lewis C; Patick AK; Duggal R
    Antimicrob Agents Chemother; 2008 Feb; 52(2):675-83. PubMed ID: 18070954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of nonnucleoside inhibitors of polymerase from infectious pancreatic necrosis virus (IPNV).
    Bello-Pérez M; Falcó A; Galiano V; Coll J; Perez L; Encinar JA
    Drug Des Devel Ther; 2018; 12():2337-2359. PubMed ID: 30104863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-Throughput Screening, Discovery, and Optimization To Develop a Benzofuran Class of Hepatitis C Virus Inhibitors.
    He S; Jain P; Lin B; Ferrer M; Hu Z; Southall N; Hu X; Zheng W; Neuenswander B; Cho CH; Chen Y; Worlikar SA; Aubé J; Larock RC; Schoenen FJ; Marugan JJ; Liang TJ; Frankowski KJ
    ACS Comb Sci; 2015 Oct; 17(10):641-52. PubMed ID: 26332742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of benzylidenebenzofuran-3(2H)-one (aurones) as inhibitors of tyrosinase derived from human melanocytes.
    Okombi S; Rival D; Bonnet S; Mariotte AM; Perrier E; Boumendjel A
    J Med Chem; 2006 Jan; 49(1):329-33. PubMed ID: 16392817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of (R)-6-cyclopentyl-6-(2-(2,6-diethylpyridin-4-yl)ethyl)-3-((5,7-dimethyl-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)methyl)-4-hydroxy-5,6-dihydropyran-2-one (PF-00868554) as a potent and orally available hepatitis C virus polymerase inhibitor.
    Li H; Tatlock J; Linton A; Gonzalez J; Jewell T; Patel L; Ludlum S; Drowns M; Rahavendran SV; Skor H; Hunter R; Shi ST; Herlihy KJ; Parge H; Hickey M; Yu X; Chau F; Nonomiya J; Lewis C
    J Med Chem; 2009 Mar; 52(5):1255-8. PubMed ID: 19209845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.